Intravenous iron supplementation in end-stage renal disease patients
- 1 March 1999
- journal article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 33 (3), 595-597
- https://doi.org/10.1016/s0272-6386(99)70199-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextransAmerican Journal of Kidney Diseases, 1999
- Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American clinical trialAmerican Journal of Kidney Diseases, 1999
- A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patientsAmerican Journal of Kidney Diseases, 1998
- Iron management in end-stage renal diseaseAmerican Journal of Kidney Diseases, 1997
- Intravenous administration of iron gluconate during haemodialysisNephrology Dialysis Transplantation, 1997
- Safety of intravenous injection of iron saccharate in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- 'Oversaturation' of transferrin after intravenous ferric gluconate (FerrlecitR) in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Iron Deficiency in Maintenance Hemodialysis Patients: Assessment of Diagnosis Criteria and of Three Different Iron TreatmentsNephron, 1991